https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-11 / Front Pharmacol 2019;10:1152
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-11 / Front Pharmacol 2019;10:11522019-10-11 00:00:002019-10-11 00:00:00Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-11 / Biomedicines 2019 Oct;7(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-11 / Biomedicines 2019 Oct;7(4)2019-10-11 00:00:002021-05-19 12:40:37Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-09 / Front Immunol 2019;10:2353
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-09 / Front Immunol 2019;10:23532019-10-09 00:00:002020-11-30 10:24:49Dendritic Cell Vaccination in Metastatic Melanoma Turns „Non-T Cell Inflamed“ Into „T-Cell Inflamed“ Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-03 / Cancers (Basel) 2019 Oct;11(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-03 / Cancers (Basel) 2019 Oct;11(10)2019-10-03 00:00:002019-10-03 00:00:00Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)2019-09-19 00:00:002020-08-26 14:07:32Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-19 / Cancers (Basel) 2019 Sep;11(9)2019-09-19 00:00:002019-09-19 00:00:00Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-11 / Front Oncol 2019;9:884
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-11 / Front Oncol 2019;9:8842019-09-11 00:00:002019-09-11 00:00:00Past, Current, and Future of Immunotherapies for Prostate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-09-01 / J. Neurosurg. 2019 09;131(3):657-6662019-09-01 00:00:002019-09-01 00:00:00The current state of immunotherapy for gliomas: an eye toward the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-30 / Biomedicines 2019 Aug;7(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-30 / Biomedicines 2019 Aug;7(3)2019-08-30 00:00:002021-11-15 13:22:59Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-27 / Front Oncol 2019;9:811
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-27 / Front Oncol 2019;9:8112019-08-27 00:00:002019-08-27 00:00:00Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
